What does Apotheek Coppens Annick do?

Apotheek Coppens Annick is a logistics company in Lille. Private Limited, started on 9 December 1991, 1 establishment.

What is the address of Apotheek Coppens Annick?

The registered office of Apotheek Coppens Annick is located at Rechtestraat 65, 2275 Lille.

Is Apotheek Coppens Annick still active?

Yes. According to the CBE (30 October 2026) Apotheek Coppens Annick is active, legal situation “Normale toestand”, started on 9 December 1991.

Is Apotheek Coppens Annick registered on Peppol?

Yes, Apotheek Coppens Annick is registered on the Peppol network with ID 0208:0446078254.

What is the enterprise number of Apotheek Coppens Annick?

The enterprise number of Apotheek Coppens Annick is BE0446078254.

When was Apotheek Coppens Annick founded?

Apotheek Coppens Annick was founded on 9 December 1991.

Who are the directors of Apotheek Coppens Annick?

According to the 2025 annual accounts, the directors of Apotheek Coppens Annick are: HELMATHEEK BV.

Is Apotheek Coppens Annick a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 December 1991; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Coppens Annick make in 2025?

Apotheek Coppens Annick posted a profit after taxes of € 120,456 in financial year 2025.

What is the revenue of Apotheek Coppens Annick?

As a small company, Apotheek Coppens Annick is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 345,542.

How much does an employee at Apotheek Coppens Annick earn?

The average wage cost per full-time employee at Apotheek Coppens Annick was € 57,000 in 2025: staff costs of € 153,822 for 2.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Coppens Annick have?

According to the 2025 annual accounts, Apotheek Coppens Annick has 2.7 full-time equivalents (FTE).

Apotheek Coppens Annick (Private Limited) - Lille

Dossier Apotheek Coppens Annick, printed on 30 October 2026 from databakkes.be/en/0446078254/apotheek-coppens-annick. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Coppens Annick from Lille, company number BE0446078254, closed financial year 2025 with a result of € 120,456 after tax. For that financial year Apotheek Coppens Annick recorded a gross margin of € 345,542 and equity of € 220,416. Compared with financial year 2024, the result moved from € 139,940 to € 120,456. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 7, 2026.

What it is worth Growing

€ 220,416

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 120,456

▼ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 314,210

▲ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 120,000 paid out

100 % of the profit went to the shareholders, mostly to HELMATHEEK (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.7

▲ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 153,822

▲ 3% vs 2024

€ 57,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,235

▼ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 194,721

▼ 15% vs 2024

€ 36,282 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 117,784

▲ 35% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 41,234

▲ 89% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 285,343 Gross margin 2022: € 285,343 First fiscal year in the series	€ 291,114 Gross margin 2023: € 291,114 ▲ 2% vs 2022 (€ 285,343) Favourable step	€ 349,314 Gross margin 2024: € 349,314 ▲ 20% vs 2023 (€ 291,114) Favourable step	€ 345,542 Gross margin 2025: € 345,542 ▼ 1% vs 2024 (€ 349,314) Unfavourable step	▼ 1%
Profit after taxes	€ 132,219 Profit after taxes 2022: € 132,219 First fiscal year in the series	€ 142,194 Profit after taxes 2023: € 142,194 ▲ 8% vs 2022 (€ 132,219) Favourable step	€ 139,940 Profit after taxes 2024: € 139,940 ▼ 2% vs 2023 (€ 142,194) Unfavourable step	€ 120,456 Profit after taxes 2025: € 120,456 ▼ 14% vs 2024 (€ 139,940) Unfavourable step	▼ 14%
Equity	€ 119,826 Equity 2022: € 119,826 First fiscal year in the series	€ 120,021 Equity 2023: € 120,021 Unchanged (€ 119,826) Favourable step	€ 219,961 Equity 2024: € 219,961 ▲ 83% vs 2023 (€ 120,021) Favourable step	€ 220,416 Equity 2025: € 220,416 Unchanged (€ 219,961) Favourable step
Total debts	€ 703,478 Total debts 2022: € 703,478 First fiscal year in the series	€ 669,627 Total debts 2023: € 669,627 ▼ 5% vs 2022 (€ 703,478) Favourable step	€ 581,861 Total debts 2024: € 581,861 ▼ 13% vs 2023 (€ 669,627) Favourable step	€ 656,864 Total debts 2025: € 656,864 ▲ 13% vs 2024 (€ 581,861) Unfavourable step	▲ 13%
Cash	€ 262,106 Cash 2022: € 262,106 First fiscal year in the series	€ 223,698 Cash 2023: € 223,698 ▼ 15% vs 2022 (€ 262,106) Unfavourable step	€ 271,740 Cash 2024: € 271,740 ▲ 21% vs 2023 (€ 223,698) Favourable step	€ 314,210 Cash 2025: € 314,210 ▲ 16% vs 2024 (€ 271,740) Favourable step	▲ 16%
Land & buildings	€ 291,121 Land & buildings 2022: € 291,121 First fiscal year in the series	€ 270,897 Land & buildings 2023: € 270,897 ▼ 7% vs 2022 (€ 291,121) Unchanged	€ 254,053 Land & buildings 2024: € 254,053 ▼ 6% vs 2023 (€ 270,897) Unchanged	€ 237,209 Land & buildings 2025: € 237,209 ▼ 7% vs 2024 (€ 254,053) Unchanged	▼ 7%
Retained profit	€ 101,226 Retained profit 2022: € 101,226 First fiscal year in the series	€ 101,421 Retained profit 2023: € 101,421 Unchanged (€ 101,226) Favourable step	€ 201,361 Retained profit 2024: € 201,361 ▲ 99% vs 2023 (€ 101,421) Favourable step	€ 201,816 Retained profit 2025: € 201,816 Unchanged (€ 201,361) Favourable step
Dividend	€ 129,300 Dividend 2022: € 129,300 First fiscal year in the series	€ 142,000 Dividend 2023: € 142,000 ▲ 10% vs 2022 (€ 129,300) Unchanged	€ 40,000 Dividend 2024: € 40,000 ▼ 72% vs 2023 (€ 142,000) Unchanged	€ 120,000 Dividend 2025: € 120,000 ▲ 200% vs 2024 (€ 40,000) Unchanged	▲ 200%
Bank debt	€ 290,483 Bank debt 2022: € 290,483 First fiscal year in the series	€ 254,396 Bank debt 2023: € 254,396 ▼ 12% vs 2022 (€ 290,483) Favourable step	€ 229,943 Bank debt 2024: € 229,943 ▼ 10% vs 2023 (€ 254,396) Favourable step	€ 194,721 Bank debt 2025: € 194,721 ▼ 15% vs 2024 (€ 229,943) Favourable step	▼ 15%
Balance sheet total	€ 823,305 Balance sheet total 2022: € 823,305 First fiscal year in the series	€ 789,648 Balance sheet total 2023: € 789,648 ▼ 4% vs 2022 (€ 823,305) Unchanged	€ 801,822 Balance sheet total 2024: € 801,822 ▲ 2% vs 2023 (€ 789,648) Unchanged	€ 877,280 Balance sheet total 2025: € 877,280 ▲ 9% vs 2024 (€ 801,822) Unchanged	▲ 9%
Employees (FTE)	2.3 Employees (FTE) 2022: 2.3 First fiscal year in the series	2.5 Employees (FTE) 2023: 2.5 ▲ 0.2 vs 2022 (2.3) Unchanged	2.4 Employees (FTE) 2024: 2.4 ▼ 0.1 vs 2023 (2.5) Unchanged	2.7 Employees (FTE) 2025: 2.7 ▲ 0.3 vs 2024 (2.4) Unchanged	▲ 0.3

Key figures of Apotheek Coppens Annick, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Coppens Annick?

What happened at Apotheek Coppens Annick in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 7, 2026 New annual accounts for financial year 2025: profit of € 120,456 (▼ 14% vs 2024). Source: NBB ↗
2009 HELMATHEEK BV became a director. NBB
Jan 15, 1992 New establishment in Lille. KBO
Dec 9, 1991 Start of the company according to the CBE. KBO

In short

From € 132,219 profit in 2022 to € 120,456 profit in 2025.

Paid € 81,114 in corporate taxes since 2022.

Best year ever: 2023, with € 142,194 profit.

On average € 128,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

HELMATHEEK 100%

The stake of HELMATHEEK comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Coppens Annick

Behind Apotheek Coppens Annick is HELMATHEEK BV. The shares are held by HELMATHEEK (100%).

Directors

According to the 2025 annual accounts

HELMATHEEK BV

Director · represented by ANNICK COPPENS

since 2009

Shareholders

HELMATHEEK

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rechtestraat 65

2275 Lille

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0446.078.254

VAT number

BE 0446.078.254

Registered office

Rechtestraat 65, 2275 Lille

Names & denominations

Apotheek Coppens Annick

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 December 1991

Peppol

Active · Active since 25 Jun 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Coppens Annick

Financials

What happened to Apotheek Coppens Annick?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions